Can the Development of Mood and Anxiety Disorders During Pregnancy and the Postpartum Period Be Anticipated in Women With Epilepsy?

Depression and anxiety disorders are the 2 most frequent psychiatric comorbidities in epilepsy.1 Higher prevalence rates of symptoms of depression and anxiety have also been reported more frequently during pregnancy and the postpartum period in pregnant women with epilepsy (PWWE) than pregnant nonepileptic women.2 Using data from the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs study, and applying a robust methodology, Meador et al.3 compared the type and prevalence of mood and anxiety disorders during pregnancy and the postpartum periods among PWWE, nonpregnant WWE, and healthy pregnant women and the epilepsy and psychiatric variables associated with their occurrence, and they report their findings in this issue of Neurology®. They are the first investigators to demonstrate a pleomorphic manifestation of mood disorders in this setting: in some women, mood disorders present as a major depressive episode (MDE), in others, as subsyndromic depressive episodes.4 Although the prevalence of MDE did not differ among pregnant and nonpregnant WWE and healthy pregnant women, subsyndromic depressive episodes were identified more frequently among PWWE during pregnancy and the postpartum period.

[1]  K. Meador,et al.  Prospective Cohort Study of Depression During Pregnancy and the Postpartum Period in Women With Epilepsy vs Control Groups , 2022, Neurology.

[2]  P. Lichtenstein,et al.  Maternal Serotonergic Antidepressant Use in Pregnancy and Risk of Seizures in Children , 2022, Neurology.

[3]  M. Brodie,et al.  ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy , 2021, Epilepsia.

[4]  A. Vignoli,et al.  Effects of postpartum depression on the behaviour of children born to mothers with epilepsy , 2019, Seizure.

[5]  T. O'Brien,et al.  The use of antidepressant drugs in pregnant women with epilepsy: A study from the Australian Pregnancy Register , 2018, Epilepsia.

[6]  A. Young,et al.  Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review. , 2017, Journal of affective disorders.

[7]  S. Patten,et al.  Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes: A Multicohort Analysis , 2017, JAMA neurology.

[8]  M. Nørgaard,et al.  Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden , 2015, PloS one.

[9]  N. Gilhus,et al.  Depression and anxiety in women with epilepsy during pregnancy and after delivery: A prospective population‐based cohort study on frequency, risk factors, medication, and prognosis , 2015, Epilepsia.

[10]  W. Hauser,et al.  Epilepsy, suicidality, and psychiatric disorders: A bidirectional association , 2012, Annals of neurology.

[11]  S. Rees,et al.  Early Life Stress Enhancement of Limbic Epileptogenesis in Adult Rats: Mechanistic Insights , 2011, PloS one.

[12]  B. Hermann,et al.  Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: Do they differ on their impact on the quality of life of patients with epilepsy? , 2010, Epilepsia.

[13]  Scott B Patten,et al.  Psychiatric Comorbidity in Epilepsy: A Population‐Based Analysis , 2007, Epilepsia.

[14]  Jennita Reefhuis,et al.  Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. , 2007, The New England journal of medicine.

[15]  J. Dungan Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects , 2008 .

[16]  N. Sadek,et al.  Subsyndromal symptomatic depression: A new concept , 2000, Depression and anxiety.